Sponsored Content
In this period, our revenue saw an impressive increase, rising from €7.87 million to €11.51 million, with a further ascension to approximately €16.5 million in 2023, demonstrating our unwavering upward trajectory and commitment to excellence. Alongside financial growth, our team has expanded from 23 to 35 members, each contributing to the company's collective success and the robustness of our brand.Employee testimonials offer a window into the company’s culture that underpins this growth. One staff member remarked, "The possibility for professional advancement here is tangible; you're not just a number, but an integral part of a grand vision". Such feedback underscores our commitment to employee development as a cornerstone of our business strategy.
.png)
Another colleague highlighted the forward-thinking environment, saying, "Innovation and adaptability are the norms here, fostering a workspace where new ideas propel us forward." It's this culture of continuous improvement that has fortified the Lo.Li. Pharma brand, earning us a spot among the revered "Growth Champions". These accolades have been mirrored by the popularity of the platform broadcasting our certification, Repubblica.it, which is among the top-visited websites in Italy, showcasing the significance of this achievement to a broad audience.The "Growth Champions of 2024" recognition is not merely an award but a reflection of Lo.Li. Pharma's strategic foresight, the vitality of our workforce, and our relentless pursuit of innovation that have consolidated the company's brand and market presence. It is a commitment to our values and a beacon guiding us toward future milestones in the health and beauty industry.
23 Feb 2026
PharmaLinea, a Slovenian developer and manufacturer of private label food supplements, has announced the completion of a clinical study evaluating its finished formulation for iron deficiency.
Read more
12 Feb 2026
Gentle and effective: magnesium bisglycinate is setting a new standard. Through its LomaChelateX® brand, Dr. Paul Lohmann® delivers magnesium bisglycinate and a broad range of fully reacted mineral bisglycinates made in Germany.
Read more
22 Jan 2026
The global leader in fucoidan science, Marinova Pty Ltd, reported record annual fucoidan production for 2025. The company's total production volume has more than doubled over the past three years.
Read more
6 Jan 2026
HYDERABAD, December 20, 2025 – India’s Prime Minister Mr. Narendra Modi, alongside WHO Director-General Dr. Tedros Adhanom Ghebreyesus, released a commemorative postal stamp honoring ashwagandha at the recently concluded Second WHO Global Traditional...
Read more
22 Dec 2025
PharmaLinea held its first-ever NutraLoop™ Summit this December. The virtual event featured 12 speakers from companies such as IQVIA, NHCO, Radicle Science, and BeyondBrands, who provided comprehensive insights across the scientific and commercia...
Read more
11 Dec 2025
Royal FrieslandCampina N.V. intends to acquire Wisconsin Whey Protein, a respected producer of whey protein isolates in the United States. Wisconsin Whey Protein will become part of FrieslandCampina Ingredients, a global leader in proteins and prebioti...
Read more
11 Dec 2025
Kaiseraugst (Switzerland), Maastricht (Netherlands), December 5, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announces ‘Frosted Star Anise’ as its Flavor of the Year for 2026. This...
Read more
11 Dec 2025
Montvale, New Jersey, (10 December, 2025) – Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health, is pleased to announce the development of a new, high-capacity man...
Read more
4 Dec 2025
Marinova has been named Australia's most outstanding contributor to international health in the nation's prestigious Australian Export Awards.
Read more
1 Dec 2025
Prayon inaugurates its new SHMP production unit in Engis, a major investment that strengthens its position in the food and technical phosphates market
Read more